Biomarkers
View abstract on PubMed
Summary
This summary is machine-generated.Sex differences in brain volume change with age. Female sex is linked to smaller occipital and larger ventricular volumes in younger adults, but these associations disappear in older age groups.
Area Of Science
- Neuroimaging
- Gerontology
- Neurodegeneration
Background
- Sex differences in aging and dementia-related neurodegeneration are not fully understood across the lifespan.
- Investigating how sex influences brain structure changes over time is crucial for understanding age-related cognitive decline.
Purpose Of The Study
- To examine sex differences in brain region volumes across different age groups.
- To determine if the association between sex and brain structure varies with age.
Main Methods
- Utilized 3T MRI data from 838 racially and ethnically diverse older adults (346 male, 492 female).
- Analyzed total cortical gray matter, hippocampus, ventricular, frontal, occipital, parietal, and temporal lobe volumes.
- Employed linear regression models and age-stratified analyses (50-74, 75-89, 90+ years) to assess sex-specific effects.
Main Results
- Female sex was associated with smaller occipital and larger ventricular volumes in adults aged 50-74.
- These associations were not significant in older age groups (75-89 and 90+).
- For individuals aged 90+, the direction of association for occipital and ventricular volumes differed compared to the younger group.
Conclusions
- The relationship between sex and brain region volume is age-dependent.
- Female sex is associated with specific brain volume differences (occipital, ventricular) in younger older adults, but not in the oldest age groups.
- Further research is needed to understand the mechanisms driving these sex-by-age interactions and their impact on cognition.
Related Concept Videos
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

